Posted on 19 February 2020 by Ella Flemyng (Methods Implementation Coordinator)

Cochrane Methods is pleased to welcome Dr Sarah Nevitt to the Cochrane Council!

Sarah Nevitt is a Research Associate in the Institute of Translational Medicine at the University of Liverpool, UK. She has been an active Cochrane author and Cochrane Methods enthusiast since 2011 and is currently the Statistical Editor of the Cochrane Epilepsy Group and the Cochrane Neuromuscular Group. She is also an active member of the Mental Health and Neuroscience Network and the Cochrane Statistics Methods Group.

Over the last nine years, Sarah has worked with many Cochrane Review Groups and Cochrane Methods Groups and has authored and supported Cochrane authors on hundreds of Cochrane reviews including a number of complex review designs, such as network meta-analyses, individual participant data meta-analysis, diagnostic test accuracy reviews and prognosis reviews. Sarah  has facilitated workshops on behalf of the Cochrane Statistics Methods Group at Cochrane Colloquia and served on the Thomas C Chalmers Award Committee for the recent Cochrane Santiago virtual Colloquium.

Sarah’s methodological experience and interests are closely aligned to the Cochrane Content Strategy and she is particularly keen to explore optimising how Cochrane groups can take on an increasing number of complex review designs to address their priority questions, and deliver these reviews to the high quality expected of Cochrane with limited resources available. She also has an active research interest in the impact of data transparency on evidence synthesis, which was the focus of her 2017 PhD thesis, including the value of unpublished data such as clinical study reports for secondary research such as Cochrane Reviews.

Sarah joins Miranda Langendam as the second methods representative on the Cochrane Council. Details on the Council and members can be found here.

Please help us welcome Sarah Nevitt to the Cochrane Council!